Trial Outcomes & Findings for Effectiveness of Supplementary Feeding During Infection Among Moderately Malnourished Children (NCT NCT00890695)

NCT ID: NCT00890695

Last Updated: 2017-08-14

Results Overview

The primary endpoint is weight for height z scores (WHZ), calculated from weight and height measures with reference to the WHO growth standards 2006. WHZ is a measure of wasting and acute malnutrition. A WHZ of zero is the median value of the reference population. Negative scores indicate undernutrition. Moderate and severe acute malnutrition are defined as WHZ\<-2 and \<-3 respectively. These correspond to 2 and 3 standard deviations below the reference median. Of all the anthropometric measures in regular use, WHZ and mid upper arm circumference (MUAC) have the strongest associations with infectious disease incidence and risk of death. WHZ is more appropriate than Weight for Age (WAZ), which is normally used in growth monitoring, because WAZ measures a combination of wasting and stunting (chronic malnutrition). Stunting is unlikely to be affected by short term intervention. WHZ is assessed by anthropometry, following WHO guidelines.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

64 participants

Primary outcome timeframe

between enrolment and 4 weeks

Results posted on

2017-08-14

Participant Flow

Recruitment was started on June 5 2009 and finished on October 8 2009. The study was terminated early because of an inadequate recruitment rate and because a donor-funded supplementary feeding programme targeting moderately malnourished children was started in September 2009.

Of the 7,132 sick children aged 6 months to 5 years seen in outpatients during the study period, 190 with a mid upper arm circumference (MUAC) \<12.5cm were assessed for eligibility. Randomization was carried out on 65 children who were eligible and whose carers consented. 1 was withdrawn: weight for height Z score (WHZ) was found to be \<-3.

Participant milestones

Participant milestones
Measure
1 Ready to Use Supplementary Food (RUSF)
Products, Kenya. The RUSF composition is in accordance with recommended supplementary feed composition specified by the latest WHO expert consultation in 2008 reported by Golden et al. It is formulated to provide 507 kcal per 100g, 6% protein/energy ratio and 55% fat/energy ratio. Essential fatty acids contained are N-6 (linoleic acid) 6 kcal % and N-3 (o-linoleic) 0.3 kcal %. Vitamin and mineral premix (3%) will provide the currently recommended nutrient intake for moderately malnourished children of minerals (K, Na, Ca, P, Mg, Fe, Zn, Cu, Se, I, Mn, Cr, Mo, F), Vitamins (thiamine, riboflavin, pyridoxine, niacin, Vit B12, folic acid, Vit C, Biotin, Pantothenic acid, Vit A, Vit D,Vit E and Vit K). initial visit. The amount supplied is based on the child's weight; the recommended energy supplement being 100kcal per kg per day which is equivalent to 25g RUSF per kg per day.
2 Normal Diet
For equity, parents or guardians of children in the usual diet arm are given 2 bags of maize meal (4Kg) for family consumption instead of RUSF. All parents and carers in both arms will also receive standard nutritional advice as specified in the current WHO IMCI handbook.
Overall Study
STARTED
32
33
Overall Study
COMPLETED
31
33
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
1 Ready to Use Supplementary Food (RUSF)
Products, Kenya. The RUSF composition is in accordance with recommended supplementary feed composition specified by the latest WHO expert consultation in 2008 reported by Golden et al. It is formulated to provide 507 kcal per 100g, 6% protein/energy ratio and 55% fat/energy ratio. Essential fatty acids contained are N-6 (linoleic acid) 6 kcal % and N-3 (o-linoleic) 0.3 kcal %. Vitamin and mineral premix (3%) will provide the currently recommended nutrient intake for moderately malnourished children of minerals (K, Na, Ca, P, Mg, Fe, Zn, Cu, Se, I, Mn, Cr, Mo, F), Vitamins (thiamine, riboflavin, pyridoxine, niacin, Vit B12, folic acid, Vit C, Biotin, Pantothenic acid, Vit A, Vit D,Vit E and Vit K). initial visit. The amount supplied is based on the child's weight; the recommended energy supplement being 100kcal per kg per day which is equivalent to 25g RUSF per kg per day.
2 Normal Diet
For equity, parents or guardians of children in the usual diet arm are given 2 bags of maize meal (4Kg) for family consumption instead of RUSF. All parents and carers in both arms will also receive standard nutritional advice as specified in the current WHO IMCI handbook.
Overall Study
Protocol Violation
1
0

Baseline Characteristics

Effectiveness of Supplementary Feeding During Infection Among Moderately Malnourished Children

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
2 Normal Diet
n=33 Participants
normal diet arm
Total
n=64 Participants
Total of all reporting groups
Age, Categorical
<=18 years
31 Participants
n=5 Participants
33 Participants
n=7 Participants
64 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
1.21 years
STANDARD_DEVIATION 0.55 • n=5 Participants
1.15 years
STANDARD_DEVIATION 0.46 • n=7 Participants
1.18 years
STANDARD_DEVIATION 0.50 • n=5 Participants
Sex: Female, Male
Female
26 Participants
n=5 Participants
23 Participants
n=7 Participants
49 Participants
n=5 Participants
Sex: Female, Male
Male
5 Participants
n=5 Participants
10 Participants
n=7 Participants
15 Participants
n=5 Participants
Region of Enrollment
Kenya
31 participants
n=5 Participants
33 participants
n=7 Participants
64 participants
n=5 Participants

PRIMARY outcome

Timeframe: between enrolment and 4 weeks

Population: All participants recruited until trial was halted

The primary endpoint is weight for height z scores (WHZ), calculated from weight and height measures with reference to the WHO growth standards 2006. WHZ is a measure of wasting and acute malnutrition. A WHZ of zero is the median value of the reference population. Negative scores indicate undernutrition. Moderate and severe acute malnutrition are defined as WHZ\<-2 and \<-3 respectively. These correspond to 2 and 3 standard deviations below the reference median. Of all the anthropometric measures in regular use, WHZ and mid upper arm circumference (MUAC) have the strongest associations with infectious disease incidence and risk of death. WHZ is more appropriate than Weight for Age (WAZ), which is normally used in growth monitoring, because WAZ measures a combination of wasting and stunting (chronic malnutrition). Stunting is unlikely to be affected by short term intervention. WHZ is assessed by anthropometry, following WHO guidelines.

Outcome measures

Outcome measures
Measure
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
2 Normal Diet
n=33 Participants
normal diet arm
Weight for Height z Score at 4 Weeks
-1.83 units on a scale
Interval -2.15 to -1.51
-1.44 units on a scale
Interval -1.65 to -1.22

SECONDARY outcome

Timeframe: between enrolment and 3 months

Population: All participants recruited until trial halted

Outcome measures

Outcome measures
Measure
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
2 Normal Diet
n=33 Participants
normal diet arm
WHZ Score at 3 Months
-1.43 Z scores
Interval -1.68 to -1.18
-1.29 Z scores
Interval -1.56 to -1.03

SECONDARY outcome

Timeframe: between enrolment and 4 weeks and at 3 months

Population: All participants recruited until trial halted

Outcome measures

Outcome measures
Measure
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
2 Normal Diet
n=33 Participants
normal diet arm
MUAC for Age Z Score at 3 Months
-1.71 Z score
Interval -1.99 to -1.43
-1.62 Z score
Interval -1.95 to -1.28

SECONDARY outcome

Timeframe: at 4 weeks and 3 months

Population: All participants recruited until trial halted

Outcome measures

Outcome measures
Measure
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
2 Normal Diet
n=33 Participants
normal diet arm
Development of Severe Malnutrition (WHZ Score <-3 and/or Kwashiorkor)
4 participants
2 participants

SECONDARY outcome

Timeframe: at 4 weeks

Population: All participants recruited until trial halted

Outcome measures

Outcome measures
Measure
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
2 Normal Diet
n=33 Participants
normal diet arm
Anemia (Hb <9.3g/dl)
16 participants
11 participants

SECONDARY outcome

Timeframe: from enrolment to 3 months

Population: All participants recruited until trial halted

Outcome measures

Outcome measures
Measure
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
2 Normal Diet
n=33 Participants
normal diet arm
Hospital Admission or Death
4 participants
5 participants

Adverse Events

1 RUSF

Serious events: 4 serious events
Other events: 0 other events
Deaths: 0 deaths

2 Normal Diet

Serious events: 5 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
1 RUSF
n=31 participants at risk
RUSF prescribed for the child for 4 weeks
2 Normal Diet
n=32 participants at risk
normal diet arm
Gastrointestinal disorders
Gastroenteritis
3.2%
1/31 • Number of events 2 • 3 months
3.1%
1/32 • Number of events 1 • 3 months
Respiratory, thoracic and mediastinal disorders
Pneumonia
3.2%
1/31 • Number of events 1 • 3 months
3.1%
1/32 • Number of events 1 • 3 months
Metabolism and nutrition disorders
Severe malnutrition
6.5%
2/31 • Number of events 3 • 3 months
9.4%
3/32 • Number of events 3 • 3 months

Other adverse events

Adverse event data not reported

Additional Information

Dr James Berkley

KEMRI/Wellcome Trust Research Programme

Phone: +254 41 522535

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place